- ￥397 - 13700
- TargetMol
- 美国
- T23521
- 2025年07月12日
企业认证
相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 保存条件：
零下80~20°C
- 保质期：
Powder: -20°C for 3 years In solvent: -80°C for 2 years
- 英文名：
VULM 1457
- 库存：
10
- 供应商：
TargetMol
- CAS号：
228544-65-8
- 规格：
500 mg/10 mg/1 mg/5 mg/2 mg/50 mg/100 mg/25 mg
| 规格： | 500 mg | 产品价格： | ￥13700.0 |
|---|---|---|---|
| 规格： | 10 mg | 产品价格： | ￥1570.0 |
| 规格： | 1 mg | 产品价格： | ￥397.0 |
| 规格： | 5 mg | 产品价格： | ￥995.0 |
| 规格： | 2 mg | 产品价格： | ￥595.0 |
| 规格： | 50 mg | 产品价格： | ￥4790.0 |
| 规格： | 100 mg | 产品价格： | ￥6850.0 |
| 规格： | 25 mg | 产品价格： | ￥3290.0 |
Product Introduction
Bioactivity
英文名:VULM 1457
描述:VULM 1457 is a potent ACAT inhibitor. VULM 1457 has remarkable hypolipidaemic activity and improves the overall myocardial ischaemia-reperfusion injury outcomes. VULM1457 significantly reduces production and secretion of adrenomedullin (AM) and down-regulates AM receptors on human hepatoblastic cells.
风险提示：丁香通仅作为第三方平台，为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全，合理判断，谨慎选购商品，商家和用户对交易行为负责。对于医疗器械类产品，请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验during biofilm formation. Herein, we describe modifications to the methodology first described by Bae et al. to utilize the mariner -based transposon bursa aurealis to generate mutants in S. epidermidis strain 1457.
and hormone secretion, as well as memory and learning (e.g.,see Curr Med Chem 14:1437–1457, 2007). Owing to the central role of SK channels, they have attracted much attention as potential drug targets, both with respect to identification of activators
Isolation of Circulating Angiogenic Cells
were found to serve as biomarkers as low levels correlate with increased cardiovascular events and death from cardiovascular causes (Werner et al. N Engl J Med 353:999–1007, 2005; Fadini et al. J Am Coll Cardiol 45:1449–1457, 2005; Hill et al. N Engl J Med 348:593–600
技术资料暂无技术资料 索取技术资料
